Copyright
©The Author(s) 2022.
World J Clin Cases. Jun 6, 2022; 10(16): 5420-5427
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5420
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5420
Table 1 Data on the patient's target lesions
| Date | The minimum diameter of perigastric malignant lymph nodes 1 (cm) | The minimum diameter of perigastric malignant lymph nodes 2 (cm) | The maximum diameter of liver metastases (cm) | The sum (cm) |
| December 13, 2019 | 1.49 | 2.15 | 1.82 | 5.46 |
| February 7, 2020 | 2.25 | 2.82 | 3.19 | 8.26 |
| April 10, 2020 | 1.54 | 1.02 | 1.71 | 4.27 |
- Citation: Liu M, Luo C, Xie ZZ, Li X. Treatment of gastric hepatoid adenocarcinoma with pembrolizumab and bevacizumab combination chemotherapy: A case report. World J Clin Cases 2022; 10(16): 5420-5427
- URL: https://www.wjgnet.com/2307-8960/full/v10/i16/5420.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i16.5420